| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/05/2010 | EP1248803B1 Nogo receptor-mediated blockade of axonal growth |
| 05/05/2010 | EP1060261B1 Poly zinc finger proteins with improved linkers |
| 05/05/2010 | EP0854917B1 Transgenic non-human animals capable of producing heterologous antibodies |
| 05/05/2010 | CN1986814B Fusion expressed product of vascular inhibine and endostatin in colibacillus and its preparing method |
| 05/05/2010 | CN1500806B HIV-lgp160 membrane protein, preparing method and uses thereof |
| 05/05/2010 | CN101701242A Method for separating bovine lactoferricin |
| 05/05/2010 | CN101701241A Preparation method of scallop active peptide |
| 05/05/2010 | CN101701240A Method for preparing antihypertensive peptide by utilizing combined enzyme enzymolysis silkworm chrysalis protein |
| 05/05/2010 | CN101701239A Method for preparing glutathione using hydantoinase |
| 05/04/2010 | USRE41318 Plant promoter sequences and methods of use for same |
| 05/04/2010 | US7709624 Process for producing recombinant protein in bacterium belonging to the genus Rhodococcus |
| 05/04/2010 | US7709618 BTL-II nucleic acids |
| 05/04/2010 | US7709603 PRO1190 polypeptides |
| 05/04/2010 | US7709601 Nylon binding peptides and methods of use |
| 05/04/2010 | US7709270 Using platelete derived growth factor as tool in detection of modulators for prevention and treatment of cell proliferative disorders |
| 05/04/2010 | US7709260 Sealing closure of bacterial ghosts by means of bioaffinity interactions |
| 05/04/2010 | US7709240 Heat resistant adenyl deaminase for enhancing taste in yeast extract; producing seasoning agent 5'-inosinic acid |
| 05/04/2010 | US7709239 Expression vector comprising nucleotide sequences coding oxidoreductase for use in generation and propagation of oils containing long-chain polyunsaturated fatty acids in yeast |
| 05/04/2010 | US7709235 5-Substituted hydantoin racemase, DNA encoding the same, recombinant DNA, transformed cell, and process for production of optically active N-carbamylamino acid or optically active amino acid |
| 05/04/2010 | US7709230 Process for producing isomaltose and uses thereof |
| 05/04/2010 | US7709229 Culturing mouse C127 cells under control of the metallothionein-1 promoter to express recombinant human growth hormone and in a Dulbecco's Modified Eagle's Medium containing trace amounts of zinc sulfate, copper sulfate and ferric citrate |
| 05/04/2010 | US7709228 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
| 05/04/2010 | US7709227 elastin-like peptides (ELP) spider structure complex including multi-leg moieties comprising ELP fusion proteins capable of forming covalent disulfide bonds; employed in peptide production and purification and/or to enhance protelytic resistance of a protein or peptide moiety in a fusion construct |
| 05/04/2010 | US7709226 Selecting variable region framework sequences from human antibody genes by comparing canonical CDR structure types for corresponding CDRs from a library of human germline antibody sequences; converting an antibody sequence of any subject species to a less immunogenic form |
| 05/04/2010 | US7709225 Nucleic acids encoding mutations in sodium channels related to epilepsy |
| 05/04/2010 | US7709224 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
| 05/04/2010 | US7709220 Methods of monitoring treatment of BAFF-R related disease |
| 05/04/2010 | US7709217 Mixture comprising hemopoietic cytokine specific immunnoglobulin for use in detection of infection and immunololgical disorders |
| 05/04/2010 | US7709214 Using antibody specific blocking agents to treat and prevent infection, cell proliferative and immunosuppressive disorders |
| 05/04/2010 | US7709202 Molecular characteristics of non-small cell lung cancer |
| 05/04/2010 | US7709196 rRNA genes from E. coli and other disease causing organisms are genetically engineered to allow identification of functional mutant ribosomes that may be used as drug targets |
| 05/04/2010 | US7709009 Immunogenic compositions for streptococcus pyogenes |
| 05/04/2010 | US7708997 antibody composition comprising a Fc region with complex N-glycoside-linked sugar chains bound to the Fc region through N-acetylglucosamines of the reducing terminal of the sugar chains |
| 05/04/2010 | US7708992 Methods for producing antibody compositions with increased ADCC |
| 05/04/2010 | US7708984 Using immunoglobulin specific to adenoid expressed chemokine (ADEC) for prevention and treatment of cell proliferative, glandular and viral infection |
| 05/04/2010 | US7708977 Method for diagnosis and treatment of vascular disease |
| 05/04/2010 | CA2418395C Protein induced by homogeneous blood transfusion and dna encoding the same |
| 05/04/2010 | CA2412880C Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product |
| 05/04/2010 | CA2384122C Cyclic depsipeptide synthetase and gene thereof, and mass production system for cyclic depsipeptide |
| 05/04/2010 | CA2318494C Angiotensin converting enzyme inhibitor |
| 05/04/2010 | CA2299624C Mammalian cytokine receptor - 11 |
| 05/04/2010 | CA2223503C Transferrin receptor genes |
| 05/04/2010 | CA2140638C Generation of xenogeneic antibodies |
| 05/04/2010 | CA2089376C Sugar modified oligonucleotides that detect and modulate gene expression |
| 05/04/2010 | CA1341604C Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon-like polypeptides |
| 04/29/2010 | WO2010048582A1 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues |
| 04/29/2010 | WO2010048432A1 Combination treatments comprising protease binding proteins for inflammatory disorders |
| 04/29/2010 | WO2010047347A1 Process for producing protein capable of forming inclusion body |
| 04/29/2010 | WO2010046094A1 Determination of immunoglobulin encoding nucleid acid |
| 04/29/2010 | WO2010045723A1 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent |
| 04/29/2010 | WO2010045710A1 Methods and reagents for enrichment and characterization of phosphorylated biomolecules |
| 04/29/2010 | WO2010022210A3 Diagnosis and monitoring of renal failure using peptide biomarkers |
| 04/29/2010 | US20100105623 Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs |
| 04/29/2010 | US20100105618 Non-Natural Recombinant Gelatins with Enhanced Functionality |
| 04/29/2010 | US20100105565 Evolved Orthogonal Ribosomes |
| 04/29/2010 | US20100105123 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/29/2010 | US20100105121 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 04/29/2010 | US20100105108 Method and device for producing vaccine |
| 04/29/2010 | US20100105107 Purification and characterization of soluble mhc proteins |
| 04/29/2010 | US20100105106 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity |
| 04/29/2010 | US20100105073 Method for the production of antibodies |
| 04/29/2010 | US20100104591 Polypeptides for inducing a protective immune response against staphylococcus epidermidis |
| 04/29/2010 | US20100104576 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response; immunization; |
| 04/29/2010 | US20100104573 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
| 04/29/2010 | US20100104568 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders |
| 04/29/2010 | US20100104564 Altered Antibody Fc Regions and Uses Thereof |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | US20100104556 Epitope-tag for surface-expressed proteins and uses thereof |
| 04/29/2010 | US20100104554 Peptide and uses thereof |
| 04/29/2010 | US20100104550 Cleavage of bip by subtilase cytotoxin |
| 04/29/2010 | US20100104535 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 04/29/2010 | US20100104531 Homogeneous preparations of il-28 and il-29 |
| 04/29/2010 | US20100104510 Selenocysteine mediated hybrid antibody molecules |
| 04/29/2010 | US20100104508 Human antibodies that bind cxcr4 and uses thereof |
| 04/29/2010 | CA2778170A1 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent |
| 04/29/2010 | CA2742043A1 Biosynthetically generated pyrroline-carboxy-lysine and site specific protein modifications via chemical derivatization of pyrroline-carboxy-lysine and pyrrolysine residues |
| 04/29/2010 | CA2741492A1 Combination treatments comprising protease binding proteins for inflammatory disorders |
| 04/29/2010 | CA2741214A1 Process for preparing inclusion body-forming protein |
| 04/29/2010 | CA2738001A1 Determination of immunoglobulin encoding nucleid acid |
| 04/28/2010 | EP2180061A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 04/28/2010 | EP2180060A1 Method for produding alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 04/28/2010 | EP2180059A1 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester |
| 04/28/2010 | EP2180049A1 Devices and compositions for lysis of occlusive blood clots while sparing wound sealing clots comprising a mutant pro-urokinase |
| 04/28/2010 | EP2180045A1 Novel protein highly producing recombinant animal cell, method for preparing the same and method for mass-producing protein using the same |
| 04/28/2010 | EP2180044A1 Antibody glycosylation variants having increased anti-body-dependent cellular cytotoxicity |
| 04/28/2010 | EP2180007A2 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/28/2010 | EP2179742A1 Compositions and methods for the treatment of immune related diseases |
| 04/28/2010 | EP2179038A1 Method for production of recombinant human thrombin '644 |
| 04/28/2010 | EP2179028A1 A novel strain of bifidobacterium and active peptides against rotavirus infections |
| 04/28/2010 | EP2178920A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178919A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP2178918A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/28/2010 | EP1427828B1 Random integration of a polynucleotide after in vivo linearization |
| 04/28/2010 | EP1346036B1 Helper virus-free herpes virus amplicon particles and uses thereof |
| 04/28/2010 | EP1259606B1 Compositions useful for regulating parkin gene activity |
| 04/28/2010 | CN1814755B High-temperature neutral protease and preparing method |
| 04/28/2010 | CN1761686B Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 04/28/2010 | CN1703426B Humanized antibodies that recognize beta amyloid peptide |
| 04/28/2010 | CN1641034B Method for preparing tetanus toxin recombinant antigen and its use |
| 04/28/2010 | CN1615359B Process for producing l-amino acid using escherichia |